Tag

The panel will discuss ESG shareholder activism and corporate business strategies, programs and policies, as related to raising capital, M&A and profitability, board and C-level engagement, internal control, disclosure and corporate governance required to address known and...

Panelists discussed private equity transactional and performance improvement strategies during the period of geopolitical and economic uncertainty, high inflation and rising interest rates, including opportunities by industry and geography, deal structures, due diligence, risk...

The panel will address the rationale, planning and structuring of a going private transaction, including transaction structures, securities regulations, disclosure and filing requirements, timelines and litigation mitigation strategies.

Latin America M&A and private equity markets are experiencing a recovery after a deal slowdown in 2022, as emerging markets investors pull out of Russia and China and focus on the LatAm region. The panel will discuss deal activity by country and industry sectors, competitive...

After a brief slowdown in 2021, shareholder activism has made a strong resurgence in 2022-23, with many new players and increased investments opportunities driven by depressed equity values. The panel will discuss the regulatory environment, SEC rules and regulations, universal...

The panel will discuss anticipated M&A activity in 2023, including most active industries and geographies.  We will address deal drivers, transaction structures, due diligence, ESG, private equity investor strategies and answer questions from the audience. This program is...

As the healthcare industry is undergoing digital transformation, healthcare providers need to prioritize data analytics and technology imperatives to drive profitability and attract investment capital.  The panel will discuss key technology drivers in healthcare, performance...

M&A activity is still significantly above pre-pandemic levels, with healthcare remaining one of the most active industries transactionally. The panel will discuss M&A trends by healthcare verticals, labor and supply chain shortages, financing availability, valuations and...

Healthcare industry’s post-pandemic resilience and scale continue to attract capital and drive consolidation.  The panel will discuss transactional drivers and headwinds, such as supply chain disruptions and increasing labor costs, financing challenges, systemic distress and...

The panel will discuss most common M&A risks and ways to mitigate them, including deal structures, corporate governance and ESG, due diligence and investigations, integration planning and transactional insurance, as well as address questions from the audience. LEADING FIRMS...